Page 132 - 《中国药房》2023年8期

[J]. Cell，2000，100（4）：423-434. hog signaling[J]. Nat Chem Biol，2013，9（4）：247-249.
[ 7 ] WU F J，ZHANG Y，SUN B，et al. Hedgehog signaling： [21] OWENS A E，DE PAOLA I，HANSEN W A，et al. Design
from basic biology to cancer therapy[J]. Cell Chem Biol， and evolution of a macrocyclic peptide inhibitor of the
2017，24（3）：252-280. sonic hedgehog/Patched interaction[J]. J Am Chem Soc，
[ 8 ] HUANGFU D W，LIU A M，RAKEMAN A S，et al. 2017，139（36）：12559-12568.
Hedgehog signalling in the mouse requires intraflagellar [22] NACHTERGAELE S，MYDOCK L K，KRISHNAN K，et
transport proteins[J]. Nature，2003，426（6962）：83-87. al. Oxysterols are allosteric activators of the oncoprotein
[ 9 ] PIETROBONO S，GAGLIARDI S，STECCA B. Non- smoothened[J]. Nat Chem Biol，2012，8（2）：211-220.
canonical hedgehog signaling pathway in cancer：activa‐ [23] WANG Y，DAVIDOW L，ARVANITES A C，et al. Gluco‐
tion of GLI transcription factors beyond smoothened[J]. corticoid compounds modify smoothened localization and
Front Genet，2019，10：556. hedgehog pathway activity[J]. Chem Biol，2012，19（8）：
[10] NIYAZ M，KHAN M S，MUDASSAR S. Hedgehog sig‐ 972-982.
naling：an Achilles’ heel in cancer[J]. Transl Oncol，2019， [24] NEDELCU D，LIU J，XU Y Q，et al. Oxysterol binding to
12（10）：1334-1344. the extracellular domain of Smoothened in hedgehog sig‐
[11] SARI I N，PHI L T H，JUN N，et al. Hedgehog signaling naling[J]. Nat Chem Biol，2013，9（9）：557-564.
in cancer：a prospective therapeutic target for eradicating [25] WANG J，ZHANG Y，HUANG W J，et al. ABT-199 inhi-
cancer stem cells[J]. Cells，2018，7（11）：208. bits hedgehog pathway by acting as a competitive inhibi‐
[12] BIAN Y H，HUANG S H，YANG L，et al. Sonic tor of oxysterol，rather as a BH3 mimetic[J]. Acta Pharma‐
hedgehog-Gli1 pathway in colorectal adenocarcinomas[J]. col Sin，2021，42（6）：1005-1013.
World J Gastroenterol，2007，13（11）：1659-1665. [26] TAO H Y，JIN Q H，KOO D I，et al. Small molecule an‐
[13] DING J，LI H Y，ZHANG L，et al. Hedgehog signaling，a tagonists in distinct binding modes inhibit drug-resistant
critical pathway governing the development and progres‐ mutant of smoothened[J]. Chem Biol，2011，18（4）：
sion of hepatocellular carcinoma[J]. Cells，2021，10 432-437.
（1）：123. [27] ROBARGE K D，BRUNTON S A，CASTANEDO G M，
[14] BAILEY J M，MOHR A M，HOLLINGSWORTH M A. et al. GDC-0449-a potent inhibitor of the hedgehog path‐
Sonic hedgehog paracrine signaling regulates metastasis way[J]. Bioorg Med Chem Lett，2009，19（19）：5576-5581.
and lymphangiogenesis in pancreatic cancer[J]. Onco‐ [28] PAN S F，WU X，JIANG J Q，et al. Discovery of NVP-
gene，2009，28（40）：3513-3525. LDE225，a potent and selective smoothened antagonist[J].
[15] MEHLMAN C，TAKAM KAMGA P，COSTANTINI A， ACS Med Chem Lett，2010，1（3）：130-134.
et al. Baseline hedgehog pathway activation and increase [29] MUNCHHOF M J，LI Q F，SHAVNYA A，et al. Disco-
of plasma Wnt1 protein are associated with resistance to very of PF-04449913，a potent and orally bioavailable in‐
immune checkpoint inhibitors in advanced non-small-cell hibitor of smoothened[J]. ACS Med Chem Lett，2012，3
lung cancer[J]. Cancers （Basel），2021，13（5）：1107. （2）：106-111.
[16] SAQUI-SALCES M，MERCHANT J L. Hedgehog sig- [30] YAUCH R L，DIJKGRAAF G J，ALICKE B，et al.
naling and gastrointestinal cancer[J]. Biochim Biophys Smoothened mutation confers resistance to a hedgehog
Acta，2010，1803（7）：786-795. pathway inhibitor in medulloblastoma[J]. Science，2009，
[17] MANZELLA G，SCHÄFER B W. Interfering with hedge‐ 326（5952）：572-574.
hog pathway：new avenues for targeted therapy in rhabdo‐ [31] TREMBLAY M R，LESCARBEAU A，GROGAN M J，et
myosarcoma[J]. Curr Drug Targets，2016，17（11）：1228- al. Discovery of a potent and orally active hedgehog path‐
1234. way antagonist （IPI-926）[J]. J Med Chem，2009，52（14）：
[18] MARTINELLI G，OEHLER V G，PAPAYANNIDIS C，et 4400-4418.
al. Treatment with PF-04449913，an oral smoothened an‐ [32] SIU L L，PAPADOPOULOS K，ALBERTS S R，et al. A
tagonist，in patients with myeloid malignancies：a phase 1 first-in-human，phase Ⅰ study of an oral hedgehog （Hh）
safety and pharmacokinetics study[J]. Lancet Haematol， pathway antagonist，BMS-833923 （XL139），in subjects
2015，2（8）：e339-e346. with advanced or metastatic solid tumors[J]. J Clin Oncol，
[19] CHANG Q，FOLTZ W D，CHAUDARY N，et al. Tumor- 2010，28（15_suppl）：2501.
stroma interaction in orthotopic primary pancreatic cancer [33] KIM J，TANG J Y，GONG R Y，et al. Itraconazole，a com‐
xenografts during hedgehog pathway inhibition[J]. Int J monly used antifungal that inhibits hedgehog pathway ac‐
Cancer，2013，133（1）：225-234. tivity and cancer growth[J]. Cancer Cell，2010，17（4）：
[20] PETROVA E，RIOS-ESTEVES J，OUERFELLI O，et al. 388-399.
Inhibitors of Hedgehog acyltransferase block sonic hedge‐ [34] KIM D J，KIM J，SPAUNHURST K，et al. Open-label，ex‐

· 1018 · China Pharmacy 2023 Vol. 34 No. 8 中国药房 2023年第34卷第8期